Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice-Reference-Cited by-同舟云学术

Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice

Published:2016-01-29 Issue:3 Volume:31 Page:337-348
ISSN:0931-0509
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:Nephrol. Dial. Transplant.

Author:

Gansevoort Ron T.,Arici Mustafa,Benzing Thomas,Birn Henrik,Capasso Giovambattista,Covic Adrian,Devuyst Olivier,Drechsler Christiane,Eckardt Kai-Uwe,Emma Francesco,Knebelmann Bertrand,Le Meur Yannick,Massy Ziad A.,Ong Albert C.M.,Ortiz Alberto,Schaefer Franz,Torra Roser,Vanholder Raymond,Więcek Andrzej,Zoccali Carmine,Van Biesen Wim

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/31/3/337/7430762/gfv456.pdf

Reference52 articles.

1. Polycystic kidney disease

2. Rare inherited kidney diseases: challenges, opportunities, and perspectives

3. Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival--an analysis of data from the ERA-EDTA Registry

4. Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney disease

5. Type of PKD1 Mutation Influences Renal Outcome in ADPKD

Cited by 205 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic effect of a vasopressin V2 receptor antagonist in acute congestive heart failure patients with hypoperfusion, the wet–cold pattern;European Journal of Clinical Pharmacology;2024-08-21

2. Ketogenic Interventions in Autosomal Dominant Polycystic Kidney Disease: A Comprehensive Review of Current Evidence;Nutrients;2024-08-13

3. [Genetic study in young patients with chronic kidney disease stage G5 from unknown etiology. The GENSEN study design;Nefrología (English Edition);2024-07

4. Improved predictions of total kidney volume growth rate in ADPKD using two-parameter least squares fitting;Scientific Reports;2024-06-14

5. How to delay the progression of chronic kidney disease: focusing on medications;Childhood Kidney Diseases;2024-06-13